Analyst firms · H.C. Wainwright · KPTI
H.C. Wainwright KPTI price target and rating history
Karyopharm Therapeutics Inc. (KPTI) · Health Care
H.C. Wainwright rates Karyopharm Therapeutics Inc. (KPTI) Neutral with a $3 price target, as of its latest action on Jul 31, 2026. It has published 5 rating actions on KPTI since August 2021, including 1 upgrade and 2 downgrades. Across 3 firms with a KPTI price target in the last 12 months, the median target is $3. H.C. Wainwright's target matches it.
- Current rating
- Neutral
- Price target
- $3
- Median target, all firms
- $3
- Actions on KPTI
- 5
H.C. Wainwright price target on KPTI
Every H.C. Wainwright rating on KPTI
- Jul 31, 2026
- Oct 13, 2025
- Jul 16, 2025
- Jul 11, 2025
- Aug 6, 2021
How other firms rate KPTI
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| H.C. Wainwright | Neutral | $3 | Jul 31, 2026 |
| Robert W. Baird | Neutral | $3 | Jul 31, 2026 |
| Rodman & Renshaw | Buy | $28 | Mar 10, 2026 |
| Cantor Fitzgerald | Overweight | Feb 5, 2026 |
Questions about H.C. Wainwright and KPTI
- What is H.C. Wainwright's price target for KPTI?
- H.C. Wainwright's latest stated price target for Karyopharm Therapeutics Inc. (KPTI) is $3, from its action on Jul 31, 2026.
- What is H.C. Wainwright's rating on KPTI?
- H.C. Wainwright rates KPTI Neutral, a neutral rating, as of Jul 31, 2026.
- When did H.C. Wainwright last change its view on KPTI?
- On Jul 31, 2026, H.C. Wainwright downgrades to Neutral from Buy, price target $3.
- How does H.C. Wainwright's KPTI target compare with other analysts?
- Across 3 firms with a KPTI price target in the last 12 months, the median target is $3. H.C. Wainwright's target matches it.
More KPTI rating histories
All H.C. Wainwright ratingsKPTI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.